dc.creator | Tsirouki T., Dastiridou A.I., Ibánez flores N., Cerpa J.C., Moschos M.M., Brazitikos P., Androudi S. | en |
dc.date.accessioned | 2023-01-31T10:16:16Z | |
dc.date.available | 2023-01-31T10:16:16Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1016/j.survophthal.2017.12.001 | |
dc.identifier.issn | 00396257 | |
dc.identifier.uri | http://hdl.handle.net/11615/80047 | |
dc.description.abstract | Orbital cellulitis (OC) is an inflammatory process that involves the tissues located posterior to the orbital septum within the bony orbit, but the term generally is used to describe infectious inflammation. It manifests with erythema and edema of the eyelids, vision loss, fever, headache, proptosis, chemosis, and diplopia. OC usually originates from sinus infection, infection of the eyelids or face, and even hematogenous spread from distant locations. OC is an uncommon condition that can affect all age groups but is more frequent in the pediatric population. Morbidity and mortality associated with the condition have declined with advances in diagnostic and therapeutic options; however, OC can still lead to serious sight- and life-threatening complications in the modern antibiotics era. Therefore, prompt diagnosis and treatment remain crucial. Antibiotic coverage, computed tomography imaging, and surgical intervention when needed have benefitted patients and changed the disease prognosis. We review the worldwide characteristics of OC, predisposing factors, current evaluation strategies, and management of the disease. © 2017 Elsevier Inc. | en |
dc.language.iso | en | en |
dc.source | Survey of Ophthalmology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042200712&doi=10.1016%2fj.survophthal.2017.12.001&partnerID=40&md5=44e0ddaaf35cc97b84feecd09a512d7a | |
dc.subject | aminoglycoside | en |
dc.subject | amoxicillin | en |
dc.subject | amoxicillin plus clavulanic acid | en |
dc.subject | antibiotic agent | en |
dc.subject | cefalotin | en |
dc.subject | cefazolin | en |
dc.subject | cefotaxime | en |
dc.subject | ceftazidime | en |
dc.subject | ceftriaxone | en |
dc.subject | cefuroxime | en |
dc.subject | cephalosporin | en |
dc.subject | chloramphenicol | en |
dc.subject | clindamycin | en |
dc.subject | cloxacillin | en |
dc.subject | flucloxacillin | en |
dc.subject | gentamicin | en |
dc.subject | metronidazole | en |
dc.subject | nafcillin | en |
dc.subject | ornidazole | en |
dc.subject | oxacillin | en |
dc.subject | penicillin derivative | en |
dc.subject | sultamicillin | en |
dc.subject | vancomycin | en |
dc.subject | antiinfective agent | en |
dc.subject | abscess | en |
dc.subject | acute leukemia | en |
dc.subject | antibiotic therapy | en |
dc.subject | brain abscess | en |
dc.subject | carotid cavernous fistula | en |
dc.subject | cat scratch disease | en |
dc.subject | cavernous sinus thrombosis | en |
dc.subject | choroid detachment | en |
dc.subject | choroiditis | en |
dc.subject | clinical feature | en |
dc.subject | computer assisted tomography | en |
dc.subject | cornea ulcer | en |
dc.subject | differential diagnosis | en |
dc.subject | disease classification | en |
dc.subject | echography | en |
dc.subject | endocrine ophthalmopathy | en |
dc.subject | endophthalmitis | en |
dc.subject | esophageal adenocarcinoma | en |
dc.subject | ethmoid bone | en |
dc.subject | eye surgery | en |
dc.subject | fracture | en |
dc.subject | giant cell arteritis | en |
dc.subject | glaucoma | en |
dc.subject | human | en |
dc.subject | infarction | en |
dc.subject | intraocular pressure abnormality | en |
dc.subject | iridocyclitis | en |
dc.subject | keratopathy | en |
dc.subject | Langerhans cell histiocytosis | en |
dc.subject | lung carcinoma | en |
dc.subject | melanoma | en |
dc.subject | meningitis | en |
dc.subject | meningoencephalitis | en |
dc.subject | mortality | en |
dc.subject | neuroblastoma | en |
dc.subject | NK T cell lymphoma | en |
dc.subject | nonhuman | en |
dc.subject | nuclear magnetic resonance imaging | en |
dc.subject | optic nerve disease | en |
dc.subject | orbit cellulitis | en |
dc.subject | ossifying fibroma | en |
dc.subject | panophthalmitis | en |
dc.subject | polyarteritis nodosa | en |
dc.subject | priority journal | en |
dc.subject | rectum carcinoma | en |
dc.subject | retina detachment | en |
dc.subject | retinoblastoma | en |
dc.subject | Review | en |
dc.subject | rhabdomyosarcoma | en |
dc.subject | sarcoidosis | en |
dc.subject | scleritis | en |
dc.subject | sepsis | en |
dc.subject | sickle cell anemia | en |
dc.subject | T cell lymphoma | en |
dc.subject | transitional cell carcinoma | en |
dc.subject | uveitis | en |
dc.subject | Wegener granulomatosis | en |
dc.subject | bacterial eye infection | en |
dc.subject | complication | en |
dc.subject | orbit cellulitis | en |
dc.subject | prognosis | en |
dc.subject | risk factor | en |
dc.subject | visual system examination | en |
dc.subject | Anti-Bacterial Agents | en |
dc.subject | Diagnosis, Differential | en |
dc.subject | Diagnostic Techniques, Ophthalmological | en |
dc.subject | Eye Infections, Bacterial | en |
dc.subject | Humans | en |
dc.subject | Ophthalmologic Surgical Procedures | en |
dc.subject | Orbital Cellulitis | en |
dc.subject | Prognosis | en |
dc.subject | Risk Factors | en |
dc.subject | Elsevier USA | en |
dc.title | Orbital cellulitis | en |
dc.type | other | en |